JOHNSON & JOHNSON — Director's Dealing 2004

May 28, 2004

SEC Form 4/A — Form 4/A

Issuer: IMMUNICON CORP (IMMC)
CIK: 0001083132
Period of Report: 2004-04-21

Reporting Person: JOHNSON & JOHNSON (10% Owner)
Reporting Person: JOHNSON & JOHNSON DEVELOPMENT CORP ET AL (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2004-04-21	Common Stock	C	1753236	—	Acquired	1758236	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2004-04-21	Series E Preferred Stock	$	C	1054853	Disposed		Common Stock (703236)	Indirect
2004-04-21	Series F Preferred Stock	$	C	1575000	Disposed		Common Stock (1050000)	Indirect

Footnotes

F1: The securities reported as being indirectly beneficially owned by the Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the Reporting Person.

F2: All of the outstanding shares of the Issuer's Series E Convertible Preferred Stock were automatically converted on a 1-for-1.5 basis into Common Stock of the Issuer upon the closing of the Issuer's initial public offering.

F3: All of the outstanding shares of the Issuer's Series F Convertible Preferred Stock were automatically converted on a 1-for-1.5 basis into Common Stock of the Issuer upon the closing of the Issuer's initial public offering.

F4: The reported transactions are not new or revised but are being reported again to gain access to the system to file this amendment, the sole purpose of which is to add Johnson & Johnson Development Corporation as a joint filer.